3 results
Approved WMOCompleted
To demonstrate the additive IOP lowering effect of SIMBRINZA (dosed BID) when added to DUOTRAV solution in subjects with open-angle glaucoma or ocular hypertension.
Approved WMORecruiting
This study aims to validate an integrated care model that is standardized and can easily be carried out in any other hospital.Primary objectiveThe primary objective is to determine the effect of a nurse-led, technology-supported, personalized careā¦
Approved WMORecruiting
The main aim of the current study is to evaluate the effectiveness of the MVC and FT additives of regular EMDR treatment a) in the therapeutic context and b) with the use of VR-based EMDR in the own living environment of children and adolescentsā¦